Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X:
“This slide just can’t catch a break. Every time I try to make it concise, a new trial drops the next day. This time it’s about the timing of complete revascularization in ACS.
After the trial showing noninferiority of the immediate approach (BIOVASC), the one showing superiority (MULTISTARS-AMI), and the one showing “non-noninferiority” (OPTION-STEMI), of course at TCT 2025 we now have the one showing “non-superiority” (iMODERN).
And since confusion clearly loves company, the next logical step is a meta-analysis — at least then the confusion will be sophisticated.”
Title: Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction
Authors: Robin Nijveldt, Michael Maeng, Casper W.H. Beijnink, Jan J. Piek, Rasha K. Al-Lamee, Luís Raposo, Sergio Bravo Baptista, Javier Escaned, Justin Davies, Igor Klem, Bahram Yosofi, Robert-Jan M. van Geuns, Christian A. Frederiksen, Lars Jakobsen, Abdelilah El Barzouhi, Dirk J. van der Heijden, Mustafa Ilhan, Saman Rasoul, Stijn Brinckman, Colette Saraber, Daniel A. Jones, Steffen E. Petersen,
Tomaž Podlesnikar, Matjaž Bunc, Marcel A.M. Beijk, Lieuwe H. Piers, Johannes B. van Rees, Henry Seligman, Graham Cole, Juan F. Iglesias, Sophie Degrauwe, Arnoud W.J. van ’t Hof, Erik Lipsic, Gabija Pundziute-do Prado, Pairoj Chattranukulchai, José F. Rodríguez-Palomares, Johannes Rigger, Martijn Meuwissen, Lennaert Kleijn, Bruno Pereira, Lorenzo Monti, René J. van der Schaaf, Juan Sanchis, Guido Belli, Jan G.P. Tijssen, Troels Thim, Niels van Royen
Read full article here.
Stay updated with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025